Shares of CryoPort, Inc. (NASDAQ:CYRX) have been assigned an average broker rating score of 1.33 (Strong Buy) from the three analysts that provide coverage for the stock, Zacks Investment Research reports. One investment analyst has rated the stock with a buy rating and two have assigned a strong buy rating to the company. CryoPort’s rating score has declined by 33% in the last 90 days as a result of various analysts’ upgrades and downgrades.

Brokerages have set a 12 month consensus price target of $7.50 for the company and are anticipating that the company will post ($0.09) EPS for the current quarter, according to Zacks. Zacks has also assigned CryoPort an industry rank of 82 out of 265 based on the ratings given to related companies.

A number of research firms have issued reports on CYRX. Janney Montgomery Scott set a $8.00 price objective on CryoPort and gave the stock a “buy” rating in a report on Wednesday, July 26th. Needham & Company LLC reiterated a “buy” rating and issued a $6.00 price objective (up previously from $4.50) on shares of CryoPort in a report on Monday, June 26th. Cowen and Company began coverage on CryoPort in a report on Friday, June 16th. They issued an “outperform” rating and a $5.50 price objective for the company. Finally, ValuEngine upgraded CryoPort from a “sell” rating to a “hold” rating in a report on Thursday, May 11th.

A hedge fund recently raised its stake in CryoPort stock. BerganKDV Wealth Management LLC raised its stake in shares of CryoPort, Inc. (NASDAQ:CYRX) by 157.5% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 25,750 shares of the company’s stock after buying an additional 15,750 shares during the period. BerganKDV Wealth Management LLC owned 0.11% of CryoPort worth $127,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 10.57% of the company’s stock.

Shares of CryoPort (CYRX) traded down 5.88% during mid-day trading on Friday, reaching $6.56. 128,809 shares of the company’s stock were exchanged. CryoPort has a one year low of $1.80 and a one year high of $7.18. The firm’s market capitalization is $157.28 million. The stock has a 50-day moving average of $5.30 and a 200 day moving average of $3.65.

TRADEMARK VIOLATION WARNING: “Analysts Expect CryoPort, Inc. (CYRX) to Announce ($0.09) EPS” was first reported by Daily Political and is the sole property of of Daily Political. If you are viewing this story on another site, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The legal version of this story can be viewed at

About CryoPort

Cryoport, Inc (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients.

Get a free copy of the Zacks research report on CryoPort (CYRX)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for CryoPort Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort Inc. and related companies with's FREE daily email newsletter.